Analyzing Tiger Legatus Capital Management's 13F Holdings from Q4 2021 to Q1 2022
Ava Hoppe | 23 April, 2023
Tiger Legatus Capital Management, LLC recently released its 13F holdings report, detailing its changes in holdings from Q4 2021 to Q1 2022. The report shows interesting shifts in stocks held by the firm, with some being sold off entirely, while others saw substantial increases in shares held.
One significant change observed was the firm's reduction in shares held in Patria Investments Limited, dropping from 1,434,137 shares to 1,040,000 shares, resulting in a 20.3% decrease in the value of its holdings. However, the firm made up for this loss by buying an additional 1,040,000 shares in the same company during Q1 2022, resulting in a 1,192.5% increase in the value of its holdings.
Tiger Legatus Capital Management also showed interest in the healthcare industry, with a remarkable increase in shares held in Tenet Healthcare Corp from none at all to 162,000 shares in Q1 2022. This purchase resulted in holdings valued at $13,926, giving a clear indication of the firm's expectations from the business.
Another observable trend was the firm's slight decrease in shares held in Expedia Group Inc, dropping from 57,500 shares to 26,200 shares in Q1 2022. This change represented a 50.7% reduction in the value of its holdings.
Also noteworthy was the firm's decrease in call options for Zynga Inc, dropping from 855,000 shares to none, representing a 100% decrease. Furthermore, the firm sold all its shares in Apollo Global Management Inc, Restaurant Brands International Inc, and Zynga Inc during Q1 2022.
In conclusion, Tiger Legatus Capital Management, LLC's 13F holdings report showed intriguing changes in holdings from Q4 2021 to Q1 2022, demonstrating the firm's flexibility and willingness to explore new investments while selling off holdings that are not performing well.
Other Posts
- Csenge Advisory Group Q1 2023 vs. Q2 2023: A Comprehensive Analysis of 13F Holdings
- Parisi Gray Wealth Management Q2 2023 vs. Q3 2023 13F Holdings Comparison
- Vernal Biosciences Announces $20MM Funding to Expand mRNA and LNP Manufacturing - Revolutionizing the Biopharma Industry
- Ferris Capital LLC's Q4 2021 to Q1 2022 13F Holdings Comparison Report: Key Findings and Changes in Holdings
- Revolutionizing Therapeutics: Flashpoint Therapeutics Receives $10M Seed Financing from Beta Lab
- Relation Insurance Services Expands Presence in Illinois with Kane Insurance Acquisition
- Northwest Investment Counselors, LLC - Q2 2023 vs. Q3 2023 13F Holdings Comparison
- A Look at Sensible Financial Planning & Management, LLC.'s Q4 2022 vs. Q1 2023 Holdings: Which Stocks Took the Lead?
- Changes in Holdings of Fund: Richard Bernstein Advisors LLC Q3 2022 vs. Q4 2022
- Mesirow Financial Investment Management, Inc. Q3 2023 vs. Q4 2023 13F Holdings Comparison